Literature DB >> 20036527

Opportunities for enhancing and integrating HIV and drug services for drug using vulnerable populations in South Africa.

Charles D H Parry1, Petal Petersen, Tara Carney, Richard Needle.   

Abstract

BACKGROUND: Little has been done to improve the integration of drug use and HIV services in sub-Saharan Africa where substance use and HIV epidemics often co-exist.
METHODS: Data were collected using rapid assessment methods in two phases in Cape Town, Durban and Pretoria, South Africa. Phase I (2005) comprised 140 key informant and focus group drug using interviewees and 19 service providers (SPs), and Phase 2 (2007) comprised 69 drug using focus group interviewees and 11 SPs.
RESULTS: Drug users put themselves at risk for HIV transmission through various drug-related sexual practices as well as through needle sharing. Drug users in both phases had limited knowledge of the availability of drug treatment services, and those that had accessed treatment identified a number of barriers, including affordability, stigma and a lack of aftercare and reintegration services. SPs identified similar barriers. Drug users displayed a general awareness of both HIV transmission routes and prevention strategies, but the findings also indicated a number of misperceptions, and problematic access to materials such as condoms and safe injection equipment. Knowledge around HIV treatment was low, and VCT experiences were mixed. SPs recognized the importance of integrating HIV and substance use services, but barriers such as funding issues, networking/referral gaps and additional burden on staff were reported in Phase 2.
CONCLUSION: A comprehensive, accessible, multi-component intervention strategy to prevent HIV risk in drug users needs to be developed including community outreach, risk reduction counselling, VCT and substance use treatment. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20036527     DOI: 10.1016/j.drugpo.2009.11.008

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  7 in total

Review 1.  people who inject drugs, HIV risk, and HIV testing uptake in sub-Saharan Africa.

Authors:  Alice K Asher; Judith A Hahn; Marie-Claude Couture; Kelsey Maher; Kimberly Page
Journal:  J Assoc Nurses AIDS Care       Date:  2012-11-17       Impact factor: 1.354

2.  Correlates of Self-Reported HIV Testing Among Patients in Specialized Substance Abuse Treatment Centers in South Africa.

Authors:  Beverley Cummings; Warren Lucas; Jacqueline Burgess; Siphokazi Dada; Charles D H Parry; Nadine Harker
Journal:  AIDS Behav       Date:  2021-05-05

3.  The Opioid Epidemic in Africa And Its Impact.

Authors:  Ann E Kurth; Peter Cherutich; Rosabelle Conover; Nok Chhun; R Douglas Bruce; Barrot H Lambdin
Journal:  Curr Addict Rep       Date:  2018-10-30

4.  'Scared of going to the clinic': Contextualising healthcare access for men who have sex with men, female sex workers and people who use drugs in two South African cities.

Authors:  Zoe Duby; Busisiwe Nkosi; Andrew Scheibe; Ben Brown; Linda-Gail Bekker
Journal:  South Afr J HIV Med       Date:  2018-01-19       Impact factor: 2.744

5.  Attitude shifts and knowledge gains: Evaluating men who have sex with men sensitisation training for healthcare workers in the Western Cape, South Africa.

Authors:  Andrew P Scheibe; Zoe Duby; Ben Brown; Eduard J Sanders; Linda-Gail Bekker
Journal:  South Afr J HIV Med       Date:  2017-03-31       Impact factor: 2.744

6.  Substance use and universal access to HIV testing and treatment in sub-Saharan Africa: implications and research priorities.

Authors:  Kathryn E Lancaster; Angela Hetrick; Antoine Jaquet; Adebola Adedimeji; Lukoye Atwoli; Donn J Colby; Angel M Mayor; Angela Parcesepe; Jennifer Syvertsen
Journal:  J Virus Erad       Date:  2018-11-15

7.  Identifying perceived barriers to monitoring service quality among substance abuse treatment providers in South Africa.

Authors:  Bronwyn Myers; Zainonisa Petersen; Rehana Kader; J Randy Koch; Ron Manderscheid; Rajen Govender; Charles D H Parry
Journal:  BMC Psychiatry       Date:  2014-02-05       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.